GRK 1331: Cell-based Characterisation of Disease Mechanisms in Tissue Destruction and Repair

生物医学基础研究领域的第一个国际研究培训小组联合了德瑞边境两侧的高水平研究机构，包括两所大型大学（ETH和苏黎世大学）和一所小型大学（康斯坦茨），以及一家小型（苏黎世Cytos）和一家大型制药企业（ALTANA Pharma，现为Nycomed，康斯坦茨）通过位于意大利Ispra的欧洲替代方法验证中心（ECVAM）与欧盟研究联系在一起。这样的联合体具有一定的规模，适合吸引最优秀的研究生和科学家。招收18名德国研究生和12名瑞士研究生。该小组由Albrecht Wendel教授（康斯坦茨大学），Klaus P. Schaefer教授（ALTANA Pharma）和Sabine Werner教授（苏黎世联邦理工学院）领导。

The first International Research Training Group in the field of biomedical basic research unites high calibre research institutions on both sides of the German-Swiss border, including two large (ETH and University of Zurich) and a small University (Konstanz), as well as a small (Cytos, Zurich) and a large pharmaceutical enterprise (ALTANA Pharma, now Nycomed, Konstanz) connected to EU research via the European Centre for the Validation of Alternative Methods (ECVAM) in Ispra/Italy. Such a consortium possesses a critical mass, which is suitable to attract the best graduate students and scientists. Eighteen German and twelve Swiss graduate students are intended. The groups are led by Prof. Dr. Albrecht Wendel (University of Konstanz), Prof. Dr. Klaus P. Schaefer (ALTANA Pharma) and Prof. Dr. Sabine Werner (ETH Zurich).